SCHEMBL120305

SCHEMBL120305

CC(=O)c1cccc(O)c1N

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 1/20 0.67
CASP7 P55210 1/20 0.67
CASP6 P55212 1/20 0.67
THRB P10828 1/20 0.52
KDM4E B2RXH2 6/20 0.50
HIF1A Q16665 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HPGD P15428 4/20 0.45
MAPT P10636 3/20 0.45
ALDH1A1 P00352 3/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
GAA P10253 1/20 0.42
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA7 P43166 3/20 0.41
CA9 Q16790 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27956714 0.98 G6PD (0.64) G6PDCASP7CASP6THRBKDM4E
Questiomycin B SCHEMBL27581895 0.91 G6PD (0.56) G6PDCASP7CASP6THRBKDM4E
SCHEMBL3498784 0.86 G6PD (0.46) G6PDCASP7CASP6THRBKDM4E
Acetaminophen SCHEMBL27938115 0.82 ALDH1A1 (0.59) G6PDCASP7CASP6KDM4EHPGD
SCHEMBL717462 0.82 G6PD (0.72) G6PDCASP7CASP6THRBKDM4E
Salicylic Acid SCHEMBL28280960 0.81 CASP7 (0.65) G6PDCASP7CASP6THRBKDM4E
SCHEMBL30504217 0.80 G6PD (0.58) G6PDCASP7CASP6THRBKDM4E
SCHEMBL27775185 0.80 G6PD (0.58) G6PDCASP7CASP6THRBKDM4E
SCHEMBL505381 0.80 MMP2 (0.47) G6PDCASP7CASP6THRBKDM4E
SCHEMBL29430959 0.80 CASP7 (1.00) G6PDCASP7CASP6THRBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1049 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120079371-A Oxygen vacancy-containing tungsten trioxide catalyst and preparation method and application thereof 南京理工大学 2025-06-03 CN claimed
US-20240368505-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF Tan Kah Kee Innovation Laboratory (CN) 2024-11-07 US claimed
WO-2023133876-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF 嘉庚创新实验室 2023-07-20 WO claimed
CN-106975014-B Preparation method and application of ginseng fruit anthocyanin 吉林农业大学 2021-02-02 CN claimed
CN-109856083-A The near-infrared quality control method of medicinal granule 广州白云山明兴制药有限公司 2019-06-07 CN claimed
CN-109503953-A A kind of capacitor polypropylene plastics shell 骆玲 2019-03-22 CN claimed
US-10196365-B2 Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof ARROMAX PHARMATECH CO., LTD. (CN) 2019-02-05 US claimed
CN-109069866-A Methods and formulations for treating and/or preventing blood-related disorders 安成生物科技股份有限公司 2018-12-21 CN claimed
CN-108904452-A A kind of preparation method of pediatric paracetamol granule 康美保宁(四川)制药有限公司 2018-11-30 CN claimed
CN-108778245-A A method of for making active constituents of medicine micronized and/or targeting synovial tissue 美蒂森 2018-11-09 CN claimed
CN-1455665-A Pharmaceutical composition DAIICHI SEIYAKU CO (JP) 2003-11-12 CN claimed
CN-1450883-A Transdermal delivery system for alkaloids of aconitum species XEL HERBACEUTICALS (US) 2003-10-22 CN claimed
CN-1102852-C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs PITMY INTERNAT N V (AN) 2003-03-12 CN claimed
CN-1397556-A Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition HE GUANGWEI (CN) 2003-02-19 CN claimed
CN-1380829-A Rapidly disintegrable tablet and process for producing the same HANMI PHARM IND CO LTD (KR) 2002-11-20 CN claimed
CN-1354640-A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents UNIV EAST CAROLINA (US) 2002-06-19 CN claimed
CN-1336823-A Compositions with improved delivery of active ingredients PROCTER & GAMBLE (US) 2002-02-20 CN claimed
CN-1246794-A Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine SEPRACOR INC (US) 2000-03-08 CN claimed
EP-0105660-B1 PREPARATION OF BIS-(AMINOPHENYL) ETHERS FROM (N-ACETYL) AMINOPHENOLS OR THEIR PHENOLATES MALLINCKRODT, INC.(a Missouri corporation) (US) 1985-11-27 EP claimed
EP-0105660-A1 Preparation of bis-(aminophenyl) ethers from (N-acetyl) aminophenols or their phenolates MALLINCKRODT, INC.(a Missouri corporation) (US) 1984-04-18 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196365-B2 Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof WEE1, WEE2, EGFR G6PD 3228/4885CASP7 1175/4885CASP6 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.